October 31, 2011
Solasia Pharma K.K. announced that it has started a PI clinical trial of darinaparsin injection (SP-02L) in patients with peripheral T-cell lymphoma (PTCL) in Japan. The trial is designed to evaluate the safety and tolerability of the compound, and around...read more